AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπΌ
RANIBIZUMAB in Zimbabwe
1 product registered with MCAZ β 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| PATIZRA SOLUTION; INJECTION | 2018/9.2/5733 | NOVARTIS PHARMA SERVICES AG | active | 31 Dec 2027 |
RANIBIZUMAB β MCAZ Registration Details
MCAZ (Zimbabwe) has 1 registered product containing RANIBIZUMAB, of which 1 is currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track RANIBIZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.